Symrise, a German chemicals company, offered to acquire the remaining shares in Swedencare, a pharmaceutical company, for SEK4.2bn. "Our full and fair offer for Swedencare’s shareholders reflects Symrise’s strong belief that Symrise is the best possible majority owner for Swedencare going forward. We intend to expand Swedencare’s leadership in premium pet healthcare products by applying our proven innovation power, long-standing industry know-how and global distribution capabilities to Swedencare’s unique product portfolio and by further extending the company’s global footprint. The global market for pet healthcare products remains stronger than ever and we are convinced that a strengthened collaboration between Symrise and Swedencare will create significant value for all shareholders," Heinz-Juergen Bertram, Symrise CEO.